{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:59Z","timestamp":1792788059823,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"deputy of research Tehran university of medical sciences","award":["Grant No. 38504"],"award-info":[{"award-number":["Grant No. 38504"]}],"id":[{"id":"https:\/\/ror.org\/01c4pz451","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-026-05445-9","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:59:20Z","timestamp":1784087960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Umbelliprenin co-formulated with selenium nanoparticles downregulates MMP-2, MMP-9 and ICAM-1 expression in triple-negative breast cancer cells MDA-MB-231"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4657-5873","authenticated-orcid":false,"given":"Farnaz","family":"Azimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-372X","authenticated-orcid":false,"given":"Ahmad Reza","family":"Shahverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-033X","authenticated-orcid":false,"given":"Hedieh Sadat","family":"Shamsnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-8555","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"8","key":"5445_CR1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/jpm11080808","volume":"11","author":"A Burguin","year":"2021","unstructured":"Burguin A, Diorio C, Durocher F. Breast cancer treatments: updates and new challenges. J personalized Med. 2021;11(8):808.","journal-title":"J personalized Med"},{"key":"5445_CR2","doi-asserted-by":"publisher","unstructured":"Maqbool M, Bekele F, Fekadu G. Treatment strategies against triple-negative breast cancer: an updated review. Breast Cancer (Dove Med Press). 2022;14:15\u201324. https:\/\/doi.org\/10.2147\/bctt.s348060.","DOI":"10.2147\/bctt.s348060"},{"issue":"9","key":"5445_CR3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3727\/096504017X14886444100783","volume":"25","author":"W Tan","year":"2017","unstructured":"Tan W, Zhu S, Cao J, Zhang L, Li W, Liu K, et al. Inhibition of MMP-2 expression enhances the antitumor effect of sorafenib in hepatocellular carcinoma by suppressing the PI3K\/AKT\/mTOR pathway. Oncol Res. 2017;25(9):1543.","journal-title":"Oncol Res"},{"issue":"2","key":"5445_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1872-034X.2008.00449.x","volume":"39","author":"Q Chen Js, Wang","year":"2009","unstructured":"Chen Js, Wang Q, Fu Xh, Huang XH, Chen Xl C, Lq, et al. Involvement of PI3K\/PTEN\/AKT\/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res. 2009;39(2):177\u201386.","journal-title":"Hepatol Res"},{"issue":"1","key":"5445_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1734-1140(09)70004-0","volume":"61","author":"C Lawson","year":"2009","unstructured":"Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009;61(1):22\u201332.","journal-title":"Pharmacol Rep"},{"issue":"3","key":"5445_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leucocyte Biology. 2020;108(3):787\u201399.","journal-title":"J Leucocyte Biology"},{"issue":"6","key":"5445_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/bph.14816","volume":"177","author":"SR Lin","year":"2020","unstructured":"Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, et al. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol. 2020;177(6):1409\u201323.","journal-title":"Br J Pharmacol"},{"key":"5445_CR8","doi-asserted-by":"publisher","unstructured":"Borchers AT. Natural Compounds in Cancer Therapy Promising Nontoxic Antitumor Agents from Plants & Other Natural Sources: by John Boik, 2001, 521 pages, softcover, $32. Oregon Medical Press, LLC, Princeton, MN. The American Journal of Clinical Nutrition. 2002;75(5):955. https:\/\/doi.org\/10.1093\/ajcn\/75.5.955a.","DOI":"10.1093\/ajcn\/75.5.955a"},{"issue":"1","key":"5445_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu JJ, Ding J. Natural Products in Cancer Therapy: Past, Present and Future. Nat Prod Bioprospect. 2021;11(1):5\u201313.","journal-title":"Nat Prod Bioprospect"},{"issue":"5","key":"5445_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/biomedicines8050126","volume":"8","author":"I Shahzadi","year":"2020","unstructured":"Shahzadi I, Ali Z, Baek SH, Mirza B, Ahn KS. Assessment of the antitumor potential of umbelliprenin, a naturally occurring sesquiterpene coumarin. Biomedicines. 2020;8(5):126.","journal-title":"Biomedicines"},{"issue":"2","key":"5445_CR11","first-page":"226","volume":"13","author":"S Mahmoodi Khatonabadi","year":"2022","unstructured":"Mahmoodi Khatonabadi S, Salami S, Mirfakhraie R, Atabakhshian R, Sirati-Sabet M, Yaghmaei BG, et al. Umbelliprenin Inhibited Angiogenesis and Metastasis of MDA-MB-231 Cell Line through Downregulation of CoCl2\/EGFMediated PI3K\/AKT\/ERK Signaling. Middle East J Cancer. 2022;13(2):226\u201336.","journal-title":"Middle East J Cancer"},{"key":"5445_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11626-016-0080-7","volume":"53","author":"M Rashidi","year":"2017","unstructured":"Rashidi M, Ahmadzadeh A, Ziai SA, Narenji M, Jamshidi H. Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line. Vitro Cell Dev Biology-Animal. 2017;53:7\u201311.","journal-title":"Vitro Cell Dev Biology-Animal"},{"issue":"1","key":"5445_CR13","first-page":"561","volume":"5","author":"V Mohanraj","year":"2006","unstructured":"Mohanraj V, Chen Y. Nanoparticles-a review. Trop J Pharm Res. 2006;5(1):561\u201373.","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"5445_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jtemb.2013.07.005","volume":"28","author":"H Forootanfar","year":"2014","unstructured":"Forootanfar H, Adeli-Sardou M, Nikkhoo M, Mehrabani M, Amir-Heidari B, Shahverdi AR, et al. Antioxidant and cytotoxic effect of biologically synthesized selenium nanoparticles in comparison to selenium dioxide. J Trace Elem Med Biol. 2014;28(1):75\u20139.","journal-title":"J Trace Elem Med Biol"},{"issue":"15","key":"5445_CR15","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.3390\/ijms22157798","volume":"22","author":"EG Varlamova","year":"2021","unstructured":"Varlamova EG, Goltyaev MV, Mal\u2019tseva VN, Turovsky EA, Sarimov RM, Simakin AV, et al. Mechanisms of the cytotoxic effect of selenium nanoparticles in different human cancer cell lines. Int J Mol Sci. 2021;22(15):7798.","journal-title":"Int J Mol Sci"},{"key":"5445_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-017-0276-3","volume":"15","author":"P Sonkusre","year":"2017","unstructured":"Sonkusre P, Cameotra SS. Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation. J Nanobiotechnol. 2017;15:1\u201312.","journal-title":"J Nanobiotechnol"},{"key":"5445_CR17","doi-asserted-by":"publisher","first-page":"154014","DOI":"10.1016\/j.phymed.2022.154014","volume":"99","author":"X-J Mi","year":"2022","unstructured":"Mi X-J, Choi HS, Perumalsamy H, Shanmugam R, Thangavelu L, Balusamy SR, et al. Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K\/Akt\/mTOR pathway in gastric cancer. Phytomedicine. 2022;99:154014.","journal-title":"Phytomedicine"},{"issue":"29","key":"5445_CR18","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1016\/j.biomaterials.2013.04.067","volume":"34","author":"Y Huang","year":"2013","unstructured":"Huang Y, He L, Liu W, Fan C, Zheng W, Wong Y-S, et al. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials. 2013;34(29):7106\u201316.","journal-title":"Biomaterials"},{"issue":"1","key":"5445_CR19","first-page":"7","volume":"56","author":"M Shakibaie","year":"2010","unstructured":"Shakibaie M, Khorramizadeh MR, Faramarzi MA, Sabzevari O, Shahverdi AR. Biosynthesis and recovery of selenium nanoparticles and the effects on matrix metalloproteinase-2 expression. Biotechnol Appl Chem. 2010;56(1):7\u201315.","journal-title":"Biotechnol Appl Chem"},{"key":"5445_CR20","doi-asserted-by":"publisher","unstructured":"Azimi F, Sanaei M, Rahimzadeh S, Ajideh R, Shahverdi AR, Yazdi MH. Effect of ursolic acid, selenium nanoparticles, and their combination on the metastasis-associated gene expression in MDA-MB-231 breast cancer cells: In-vitro study. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-3342362\/v1.","DOI":"10.21203\/rs.3.rs-3342362\/v1"},{"issue":"6","key":"5445_CR21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1039\/D3SU00145H","volume":"1","author":"D Medina-Cruz","year":"2023","unstructured":"Medina-Cruz D, Truong LB, Sotelo E, Mart\u00ednez L, Gonz\u00e1lez MU, Huttel Y, et al. Bacterial-mediated selenium nanoparticles as highly selective antimicrobial agents with anticancer properties. RSC Sustain. 2023;1(6):1436\u201348.","journal-title":"RSC Sustain"},{"key":"5445_CR22","first-page":"533","volume":"24","author":"L Gkionis","year":"2020","unstructured":"Gkionis L, Kavetsou E, Kalospyros A, Manousakis D, Garzon Sanz M, Butterworth S, et al. Investigation of the cytotoxicity of bioinspired coumarin analogues towards human breast cancer cells. Mol Diversity. 2020;24:533\u201341.","journal-title":"Mol Diversity"},{"issue":"1","key":"5445_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11626-016-0080-7","volume":"53","author":"M Rashidi","year":"2017","unstructured":"Rashidi M, Ahmadzadeh A, Ziai SA, Narenji M, Jamshidi H. Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line. Vitro Cell Dev Biol Anim. 2017;53(1):7\u201311.","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"5445_CR24","doi-asserted-by":"publisher","unstructured":"Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int J Mol Sci. 2021;22(23). https:\/\/doi.org\/10.3390\/ijms222312827.","DOI":"10.3390\/ijms222312827"},{"issue":"6","key":"5445_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","volume":"70","author":"KD Miller","year":"2020","unstructured":"Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. Cancer J Clin. 2020;70(6):443\u201359.","journal-title":"Cancer J Clin"},{"key":"5445_CR26","doi-asserted-by":"publisher","unstructured":"Bergin AR, Loi S. Triple-negative breast cancer: recent treatment advances. F1000Research. 2019;8:F1000 Faculty Rev\u2013342. https:\/\/doi.org\/10.12688\/f1000research.18888.1.","DOI":"10.12688\/f1000research.18888.1"},{"issue":"7","key":"5445_CR27","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","volume":"15","author":"O Obidiro","year":"2023","unstructured":"Obidiro O, Battogtokh G, Akala EO. Triple negative breast cancer treatment options and limitations: future outlook. Pharmaceutics. 2023;15(7):1796.","journal-title":"Pharmaceutics"},{"issue":"7","key":"5445_CR28","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/molecules27072165","volume":"27","author":"MR Islam","year":"2022","unstructured":"Islam MR, Islam F, Nafady MH, Akter M, Mitra S, Das R, et al. Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint. Molecules. 2022;27(7):2165.","journal-title":"Molecules"},{"key":"5445_CR29","doi-asserted-by":"publisher","first-page":"105694","DOI":"10.1016\/j.tiv.2023.105694","volume":"93","author":"\u00d6S Aslant\u00fcrk","year":"2023","unstructured":"Aslant\u00fcrk \u00d6S, \u00c7elik TA. Anticancer effect of umbelliferone on MKN-45 and MIA PaCa-2 cell lines. Toxicol In Vitro. 2023;93:105694.","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"5445_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.5530\/ijper.58.3.97","volume":"58","author":"M Albratty","year":"2024","unstructured":"Albratty M, Makeen HA. An Umbelliferone-induced Caspase-Mediated Apoptosis in MDA-MB-231 Breast Cancer Cells. Indian J Pharm Educ Res. 2024;58(3):890\u20138.","journal-title":"Indian J Pharm Educ Res"},{"issue":"1","key":"5445_CR31","doi-asserted-by":"publisher","first-page":"11770","DOI":"10.1038\/s41598-024-62747-z","volume":"14","author":"M Shakiba","year":"2024","unstructured":"Shakiba M, Rassouli FB. Joining up the scattered anticancer knowledge on auraptene and umbelliprenin: a meta-analysis. Sci Rep. 2024;14(1):11770.","journal-title":"Sci Rep"},{"issue":"sup1","key":"5445_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107 A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177\u201383.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5445_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-012-0335-4","volume":"30","author":"S Zhao","year":"2013","unstructured":"Zhao S, Ma W, Zhang M, Tang D, Shi Q, Xu S, et al. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Med Oncol. 2013;30:1\u20138.","journal-title":"Med Oncol"},{"issue":"3","key":"5445_CR34","first-page":"422","volume":"8","author":"Y-C Chien","year":"2018","unstructured":"Chien Y-C, Liu L-C, Ye H-Y, Wu J-Y, Yu Y-L. EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2\/-9 pathway. Am J cancer Res. 2018;8(3):422.","journal-title":"Am J cancer Res"},{"issue":"1","key":"5445_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-018-0937-3","volume":"18","author":"G S\u00f6keland","year":"2019","unstructured":"S\u00f6keland G, Schumacher U. The functional role of integrins during intra-and extravasation within the metastatic cascade. Mol Cancer. 2019;18(1):12.","journal-title":"Mol Cancer"},{"issue":"34","key":"5445_CR36","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1038\/sj.onc.1205684","volume":"21","author":"E Fiore","year":"2002","unstructured":"Fiore E, Fusco C, Romero P, Stamenkovic I. Matrix metalloproteinase 9 (MMP-9\/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene. 2002;21(34):5213\u201323.","journal-title":"Oncogene"},{"key":"5445_CR37","doi-asserted-by":"publisher","first-page":"849701","DOI":"10.3389\/fimmu.2022.849701","volume":"13","author":"O Regev","year":"2022","unstructured":"Regev O, Kizner M, Roncato F, Dadiani M, Saini M, Castro-Giner F, et al. ICAM-1 on breast cancer cells suppresses lung metastasis but is dispensable for tumor growth and killing by cytotoxic T cells. Front Immunol. 2022;13:849701.","journal-title":"Front Immunol"},{"issue":"1","key":"5445_CR38","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1038\/s41467-021-25189-z","volume":"12","author":"R Taftaf","year":"2021","unstructured":"Taftaf R, Liu X, Singh S, Jia Y, Dashzeveg NK, Hoffmann AD, et al. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nat Commun. 2021;12(1):4867.","journal-title":"Nat Commun"},{"issue":"7","key":"5445_CR39","doi-asserted-by":"publisher","first-page":"e0207169","DOI":"10.1371\/journal.pone.0207169","volume":"14","author":"L Zhang","year":"2019","unstructured":"Zhang L, Sun X, Si J, Li G, Cao L. Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and migration through the disturbance of Wnt signaling pathway in gastric cancer. PLoS ONE. 2019;14(7):e0207169.","journal-title":"PLoS ONE"},{"issue":"3","key":"5445_CR40","first-page":"976","volume":"17","author":"MN Alizadeh","year":"2018","unstructured":"Alizadeh MN, Rashidi M, Muhammadnejad A, Zanjani TM, Ziai SA. Antitumor effects of umbelliprenin in a mouse model of colorectal cancer. Iran J Pharm research: IJPR. 2018;17(3):976.","journal-title":"Iran J Pharm research: IJPR"},{"issue":"14","key":"5445_CR41","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1002\/cam4.6170","volume":"12","author":"H Wang","year":"2023","unstructured":"Wang H, Liu Y, Wang Y, Xu T, Xia G, Huang X. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells. Cancer Med. 2023;12(14):15277\u201388.","journal-title":"Cancer Med"},{"issue":"11","key":"5445_CR42","doi-asserted-by":"publisher","first-page":"8908","DOI":"10.1002\/jcp.26814","volume":"233","author":"M Rashidi","year":"2018","unstructured":"Rashidi M, Khalilnezhad A, Amani D, Jamshidi H, Muhammadnejad A, Bazi A, et al. Umbelliprenin shows antitumor, antiangiogenesis, antimetastatic, anti-inflammatory, and immunostimulatory activities in 4T1 tumor\u2010bearing Balb\/c mice. J Cell Physiol. 2018;233(11):8908\u201318.","journal-title":"J Cell Physiol"},{"issue":"3","key":"5445_CR43","first-page":"1","volume":"11","author":"S Mahmoodi Khatonabadi","year":"2024","unstructured":"Mahmoodi Khatonabadi S, Atabakhshian R, Mirfakhraie R, Ghafghazi S. Effect of Umbelliprenin on HIF-1\u03b1-Driven Angiogenesis Induced by EGF and CoCl2 in T47D Cell Line. Res J Pharmacognosy. 2024;11(3):1\u201313.","journal-title":"Res J Pharmacognosy"},{"key":"5445_CR44","doi-asserted-by":"publisher","first-page":"598997","DOI":"10.3389\/fbioe.2020.598997","volume":"8","author":"J Tian","year":"2020","unstructured":"Tian J, Wei X, Zhang W, Xu A. Effects of selenium nanoparticles combined with radiotherapy on lung cancer cells. Front Bioeng Biotechnol. 2020;8:598997.","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"5445_CR45","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1039\/D1MA00639H","volume":"3","author":"N Bisht","year":"2022","unstructured":"Bisht N, Phalswal P, Khanna PK. Selenium nanoparticles: A review on synthesis and biomedical applications. Mater Adv. 2022;3(3):1415\u201331.","journal-title":"Mater Adv"},{"issue":"1","key":"5445_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.18240\/ijo.2024.01.02","volume":"17","author":"F Dastaviz","year":"2024","unstructured":"Dastaviz F, Vahidi A, Khosravi T, Khosravi A, Arabi MS, Bagheri A, et al. Impact of umbelliprenin-containing niosome nanoparticles on VEGF-A and CTGF genes expression in retinal pigment epithelium cells. Int J Ophthalmol. 2024;17(1):7.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"5445_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1061186X.2024.2412142","volume":"33","author":"MA Waqar","year":"2025","unstructured":"Waqar MA. A comprehensive review on recent advancements in drug delivery via selenium nanoparticles. J Drug Target. 2025;33(2):157\u201370.","journal-title":"J Drug Target"},{"issue":"3","key":"5445_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/nano13030424","volume":"13","author":"MC Zambonino","year":"2023","unstructured":"Zambonino MC, Quizhpe EM, Mouheb L, Rahman A, Agathos SN, Dahoumane SA. Biogenic selenium nanoparticles in biomedical sciences: properties, current trends, novel opportunities and emerging challenges in theranostic nanomedicine. Nanomaterials. 2023;13(3):424.","journal-title":"Nanomaterials"},{"key":"5445_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-21-33","volume":"21","author":"MH Yazdi","year":"2013","unstructured":"Yazdi MH, Mahdavi M, Setayesh N, Esfandyar M, Shahverdi AR. Selenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic form of mouse breast cancer. DARU J Pharm Sci. 2013;21:1\u20139.","journal-title":"DARU J Pharm Sci"},{"key":"5445_CR50","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00449-012-0867-1","volume":"36","author":"C Ramamurthy","year":"2013","unstructured":"Ramamurthy C, Sampath K, Arunkumar P, Kumar MS, Sujatha V, Premkumar K, et al. Green synthesis and characterization of selenium nanoparticles and its augmented cytotoxicity with doxorubicin on cancer cells. Bioprocess Biosyst Eng. 2013;36:1131\u20139.","journal-title":"Bioprocess Biosyst Eng"},{"key":"5445_CR51","doi-asserted-by":"publisher","first-page":"1159193","DOI":"10.3389\/fbioe.2023.1159193","volume":"11","author":"D Kulkarni","year":"2023","unstructured":"Kulkarni D, Sherkar R, Shirsathe C, Sonwane R, Varpe N, Shelke S, et al. Biofabrication of nanoparticles: sources, synthesis, and biomedical applications. Front Bioeng Biotechnol. 2023;11:1159193.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"5445_CR52","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1021\/acs.jnatprod.7b00175","volume":"80","author":"S Genovese","year":"2017","unstructured":"Genovese S, Taddeo VA, Epifano F, Fiorito S, Bize Cc, Rives A, et al. Characterization of the degradation profile of umbelliprenin, a bioactive prenylated coumarin of a Ferulago species. J Nat Prod. 2017;80(9):2424\u201331.","journal-title":"J Nat Prod"},{"key":"5445_CR53","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.genrep.2022.101732","volume":"30","author":"E Kamalkazemi","year":"2023","unstructured":"Kamalkazemi E, Dehghan G, Abedi-Gaballu F, Babaei E, Baradaran B. Umbelliprenin-loaded nanostructured lipid carrier: A novel approach for inducing cytotoxicity and apoptosis in colorectal cancer cells by altering the p53, survivin, and Bax\/Bcl2 ratio. Gene Rep. 2023;30:101732.","journal-title":"Gene Rep"},{"issue":"1\u20132","key":"5445_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.phymed.2007.04.001","volume":"15","author":"C Barthomeuf","year":"2008","unstructured":"Barthomeuf C, Lim S, Iranshahi M, Chollet P. Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine. 2008;15(1\u20132):103\u201311.","journal-title":"Phytomedicine"},{"key":"5445_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.colsurfb.2012.02.006","volume":"94","author":"H Luo","year":"2012","unstructured":"Luo H, Wang F, Bai Y, Chen T, Zheng W. Selenium nanoparticles inhibit the growth of HeLa and MDA-MB-231 cells through induction of S phase arrest. Colloids Surf B. 2012;94:304\u20138.","journal-title":"Colloids Surf B"},{"issue":"7","key":"5445_CR56","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Lehmann BD, Burstein MD, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. Comprehensive genomic analysis identifies novel subtypes of triple-negative breast cancer. J Clin Invest. 2011;121(7):2750\u201367.","journal-title":"J Clin Invest"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05445-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:02:46Z","timestamp":1791435766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05445-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5445"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05445-9","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have read and reviewed the manuscript and consented to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}